| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad1f2c153505db8151859ff19525ca74 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-54 |
| filingDate |
1999-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42961122431c2c5d1ea15f7d74076247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9672da2e5af3eae072b62697c644124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1069b42615b9db54dfbd763d4e52fb4d |
| publicationDate |
2003-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6514710-B1 |
| titleOfInvention |
Method of using cyclic peptides to inhibit binding to urokinase-type plasminogen activator receptor |
| abstract |
Cyclic peptide compounds having 11 amino acids joined by a linking unit L, such that the linear dimension between the Calpha carbon of the first amino acid and the Calpha carbon of eleventh amino acid is between about 4 and 12 Ångstrom units; are useful for inhibiting the binding of uPA to the uPAR receptor. Methods for using the cyclic peptide compounds, and compositions containing them, for inhibiting the growth or metastasis of cancerous tumors are also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10975121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011190214-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006036071-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101248350-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940704-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004204348-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015152137-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603385-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006036071-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324798-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441625-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8568689-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10994032-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011287040-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311637-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3590542-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884131-B2 |
| priorityDate |
1996-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |